Navigation Links
Neusoft Medical's Latest Innovation, NeuViz 16 CT Scanner, Approved by FDA for the U.S. Market
Date:7/24/2009

SHENYANG, China, July 24 /PRNewswire-Asia/ -- Neusoft Medical Systems Co., Ltd. (Neusoft Medical), a wholly owned subsidiary of Neusoft Corporation (600718.SH), officially announced that its newly developed Computed Tomography(CT) system, NeuViz 16 multi-slice CT scanner, has been approved by the FDA recently, and is also marked as the first of its kind in China. As its first 16 multi-slice CT scanner was shipped to its U.S.-based customers recently, Neusoft Medical has made its newest innovation entered into the global high-end medical market, indicating another breakthrough for the company in the field of high-end medical equipment, following its introduction of PET system in May 2009.

(Logo: http://www.newscom.com/cgi-bin/prnh/20061219/CNTU012LOGO )

NeuViz 16 multi-slice CT scanner is designed with the latest integrated detector for optimized SNR and scanning time, and its patented technology of dynamic focal spot ensures a higher spatial resolution during scanning and creates more detailed 3D/MPR images. The product also features DoseRight Modulation as well as a pediatric protocol to ensure optimized dose without compromising image quality.

One of the core technologies of CT is embedded software, which determines the quality and operating speed of CT imaging, according to Mr. Liu Jian, Vice President of Neusoft Corporation & President of Neusoft Medical. Based on its own accumulated experience and strength in software, Neusoft Medical has always been sticking to the combination strategy of independent development and open innovation. This has enabled the company to successfully develop a series of products, including single-slice, dual-slice, and 16-slice CT scanners. Meanwhile, it has researched and developed a series of computer-aided diagnostic (CAD) software in a variety of specialties to greatl
'/>"/>

SOURCE Neusoft Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Neusoft Becomes First Global Growth Company Partner of World Economic Forum
2. Home Health Care Supplies 'Order Themselves' with New Auto Reorder from TheMedicalSupplyDepot.com
3. TheMedicalSupplyDepot.com Announces New Discount Medical Supplies MSD Club
4. Hooper Holmes Concludes Sale of Medicals Direct
5. St. John's Hospital Acquires Latest Technology in Robotic-Assisted Surgery
6. GetWellNetwork Introduces Discharge Planning Tools in Latest Version of PatientLife System
7. Zenger Folkman Releases Latest Book: The Inspiring Leader: Unlocking the Secrets of How Extraordinary Leaders Motivate
8. Latest Studies Show Junk Drinks Pose as Many Health Threats as Junk Food According to AquaHydrate Medical Advisor
9. News from the Latest Issue of Molecular Medicine Kicking The Habit - It's In The Genes
10. Latest Berry Health Benefits Revealed
11. Patients Spent an Average of Four Hours and Three Minutes in U.S. Emergency Departments in 2008, According to Latest Press Ganey Report
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)... water and fruit consumption leads to success, st...y News) -- Increased exercise, reduced soda consum...ve weight control strategies for adolescents, a ne...scents about their weight-control strategies and l... weight and 68 had not. The responses were grouped...
(Date:12/4/2009)...ec. 4 Substantial progress has bee...mmunity,s ability to diagnose and treat epilepsy a...sy management has not reached most of the 50 milli...nearly three million people in the United States w... Schachter, M.D., president of the American Epilep...
(Date:12/4/2009)...lance urged for at-risk patient groups , ...od cancers, particularly Ewing sarcomas and centra...currence, U.S. researchers have found. , The st...rvivors of the most common pediatric cancers who w...y. , The researchers found that the overall can...
(Date:12/4/2009)...erol-lowering drugs known as statins are among the...tudy by researchers at Fred Hutchinson Cancer Rese...m cell transplant patients from one of the most se...apy: graft-versus-host disease, or GVHD. The findi...e journal Blood . , In a retrospective study of ...
(Date:12/4/2009)... of risks, many hesitate to take breast cancer dru...hDay News) -- Worries about side effects are a maj...high risk for breast cancer are willing to take th...dy finds. , In an effort to inform women about ...t the University of Michigan Comprehensive Cancer ...
Breaking Medicine News(10 mins):Health News:Teens Lose More Weight Using Healthy Strategies 2Health News:Epilepsy Patients Caught in Treatment Gap and Not Getting State-of-the-Art Care 2Health News:Epilepsy Patients Caught in Treatment Gap and Not Getting State-of-the-Art Care 3Health News:Epilepsy Patients Caught in Treatment Gap and Not Getting State-of-the-Art Care 4Health News:Cholesterol-lowering drugs also may protect stem cell transplant patients from GVHD 2Health News:High-Risk Women May Often Avoid Using Tamoxifen 2
...wait Ministry of Health stockpiles thyroid-blockin...es , , MOORESVILLE, N.C., Jan. 22 Nukepills.com ...lion doses) of ThyroShield(TM) Potassium Iodide to...otecting its citizens during a nuclear radiation e...
...MILTON, Bermuda, Jan. 22 Warner Chilcott Limited ...ue its 2009 Financial Guidance after market close ...ng a press release, Roger Boissonneault, President... discuss the 2009 Financial Guidance for all inter...
... , , , , CARLSBAD, Cal...automated molecular testing solutions announced to... to demonstrate the value of genetic variants in d...artery disease, peripheral vascular disease and ce...
... Health Industry Professiona...ama , New York (PRWEB) Ja...published a brief entitled 10 Minutes on Health R...are coverage for the nation,s employers and the ...
... To encourage dental care i...edures, including the anesthesia, from January thr...od dental health, you may avoid some serious and e...g the health and well-being of your pets. The numb...
... recent survey by Medical College of Wisconsin res...ert Hospital Emergency Department revealed that Me...ell prepared for disasters as the rest of the coun...22, 2009. , The purpose of the survey was to ass...
Other Medicine News:Health News:Kuwait Purchases 5.4 Million Doses of Emergency Nuclear Radiation Drug from Nukepills.com 2Health News:AutoGenomics CYP 2C19 Test Used in Study to Personalize Clopidogrel (Plavix) Dosing in Patients 2Health News:Media Alert: PricewaterhouseCoopers Publishes Brief on the Impact of Government Health Reform on U.S. Employers 2Health News:Media Alert: PricewaterhouseCoopers Publishes Brief on the Impact of Government Health Reform on U.S. Employers 3Health News:Media Alert: PricewaterhouseCoopers Publishes Brief on the Impact of Government Health Reform on U.S. Employers 4Health News:Indian Head Animal Hospital Announces Dental Discounts for Pets through March 31st 2Health News:Personal disaster preparedness 2
(Date:12/4/2009)... Md., Dec. 4 Northwest B...C Bulletin Board: NWBO) announced today that the U...nt application on a system for automation of the i...DCVax® therapeutic cancer vaccines. These in...h concentration of dendritic cells (which are the ...
(Date:12/3/2009)...RK, Dec. 3 Guidepoint Global, LLC...d the launch of their Sleep Apnea Tracker, a month...jects trends and market share in the worldwide Sle...ptures actual patient usage for 87 different Sleep...15 different equipment providers going back to Jan...
(Date:12/3/2009)..., N.J., Dec. 3 A genetic...eveloping a potentially life-threatening blood dis...es or chemicals is one of several medical discover...Diagnostics (NYSE: DGX ) will present during the...Meeting and Exposition, December 5-8, 2009, in New...
Breaking Medicine Technology:Northwest Biotherapeutics Receives Approval of US Patent for Cost Saving Automation of High-Concentration DCVax(R) Manufacturing 2Northwest Biotherapeutics Receives Approval of US Patent for Cost Saving Automation of High-Concentration DCVax(R) Manufacturing 3Northwest Biotherapeutics Receives Approval of US Patent for Cost Saving Automation of High-Concentration DCVax(R) Manufacturing 4Northwest Biotherapeutics Receives Approval of US Patent for Cost Saving Automation of High-Concentration DCVax(R) Manufacturing 5Leading Primary Research Firm Guidepoint Global Announces Launch of Sleep Apnea Tracker 2Quest Diagnostics Reveals New Genetic Discoveries for Testing for Leukemia, Lymphoma and Blood Clotting at 51st ASH Meeting and Exposition 2Quest Diagnostics Reveals New Genetic Discoveries for Testing for Leukemia, Lymphoma and Blood Clotting at 51st ASH Meeting and Exposition 3Tiny Batteries Can Cause Big Problems for Young Children 58870 1Tiny Batteries Can Cause Big Problems for Young Children 58870 28 Ounces a Day of POM Wonderful 100 25 Pomegranate Juice May Slow Progression of Carotid Intima Media Thickness 28CIMT 29 in Patients with Elevated C 58866 18 Ounces a Day of POM Wonderful 100 25 Pomegranate Juice May Slow Progression of Carotid Intima Media Thickness 28CIMT 29 in Patients with Elevated C 58866 28 Ounces a Day of POM Wonderful 100 25 Pomegranate Juice May Slow Progression of Carotid Intima Media Thickness 28CIMT 29 in Patients with Elevated C 58866 3American HealthTech and Vocollect Healthcare Systems Announce an Alliance to Deliver Unified Electronic Medical Records 58862 1American HealthTech and Vocollect Healthcare Systems Announce an Alliance to Deliver Unified Electronic Medical Records 58862 2American HealthTech and Vocollect Healthcare Systems Announce an Alliance to Deliver Unified Electronic Medical Records 58862 3
...ls that multiply and migrate in the, embryo to giv... a finding, that suggests that these cells might ...n., Oct. 3 Investigators at St.,Jude Children,s R...he,origin of the mammalian lymphatic vasculature -...to various essential housekeeping functions in the...
...maceuticals, Inc. (Nasdaq: TPPH ) announced today...i-center study of TPI 287 in patients with,advance...ial exploring the,activity of TPI 287 in various t...this year in advanced hormone refractory prostate ...oved for pancreatic cancer and,effective treatment...
Other Medicine Technology:St. Jude Settles Century-Old Debate on Origin of Mammalian Network of Lymphatic Vessels 2Tapestry Initiates Phase 2 Trial of TPI 287 for the Treatment of Advanced Pancreatic Cancer 2Tapestry Initiates Phase 2 Trial of TPI 287 for the Treatment of Advanced Pancreatic Cancer 3Tapestry Initiates Phase 2 Trial of TPI 287 for the Treatment of Advanced Pancreatic Cancer 4Tapestry Initiates Phase 2 Trial of TPI 287 for the Treatment of Advanced Pancreatic Cancer 5
Vascular ClearWay Irrigating PTFE Balloon Catheter
PureVision Contact Lenses
Arx™ Ceramic Spinal Spacer System™
QC 900 Hematocrit Control
Medicine Products: